Home LiteratureArticle Details
PMID: 11901186 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

The Journal of clinical investigation ·Vol. 109 ·No. 6 ·2002-03-00 ·Pages 777-85

Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G

Abstract

Tumors have been thought to initiate as avascular aggregates of malignant cells that only later induce vascularization. Recently, this classic concept of tumor angiogenesis has been challenged by the suggestion that tumor cells grow by co-opting preexisting host vessels and thus initiate as well-vascularized tumors without triggering angiogenesis. To discriminate between these two mechanisms, we have used intravital epifluorescence microscopy and multi-photon laser scanning confocal microscopy to visualize C6 microglioma vascularization and tumor cell behavior. To address the mechanisms underlying tumor initiation, we assessed the expression of VEGF, VEGF receptor-2 (VEGFR-2), and angiopoietin-2 (Ang-2), as well as endothelial cell proliferation. We show that multicellular aggregates (<< 1 mm(3)) initiate vascular growth by angiogenic sprouting via the simultaneous expression of VEGFR-2 and Ang-2 by host and tumor endothelium. Host blood vessels are not co-opted by tumor cells but rather are used as trails for tumor cell invasion of the host tissue. Our data further suggest that the established microvasculature of growing tumors is characterized by a continuous vascular remodeling, putatively mediated by the expression of VEGF and Ang-2. The results of this study suggest a new concept of vascular tumor initiation that may have important implications for the clinical application of antiangiogenic strategies.

MeSH Terms
Angiopoietin-2 Animals Cell Division Cell Transplantation Cerebral Cortex Endothelial Growth Factors/genetics,metabolism Endothelium, Vascular/metabolism,pathology Enzyme Inhibitors/metabolism Immunohistochemistry In Situ Hybridization Lymphokines/genetics,metabolism Mice Mice, Nude Microscopy, Confocal/methods Muscle, Skeletal Neoplasm Transplantation Neoplasms, Experimental/blood supply,metabolism,pathology Neovascularization, Pathologic/metabolism,physiopathology Platelet Endothelial Cell Adhesion Molecule-1/genetics,metabolism Proteins/genetics,metabolism Rats Receptor Protein-Tyrosine Kinases/antagonists & inhibitors,genetics,metabolism Receptors, Growth Factor/genetics,metabolism Receptors, Vascular Endothelial Growth Factor Tumor Cells, Cultured Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Angiopoietin-2 Endothelial Growth Factors Enzyme Inhibitors Lymphokines Platelet Endothelial Cell Adhesion Molecule-1 Proteins Receptors, Growth Factor Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Receptor Protein-Tyrosine Kinases Receptors, Vascular Endothelial Growth Factor
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Vajkoczy Peter
Department of Neurosurgery, Klinikum Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 103, D-68167 Mannheim, Germany. peter.vajkoczy@nch.ma.uni-heidelberg.de
Farhadi Mohammad
Gaumann Andreas
Heidenreich Regina
Erber Ralf
Wunder Andreas
Tonn Jörg C
Menger Michael D
Breier Georg
References (42)
42 references, click to expand
  1. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.
    Development. 1992 Feb;114(2):521-32 PMID: 1592003
  2. C6 glioma cell invasion and migration of rat brain after neural homografting: ultrastructure.
    Neurosurgery. 1990 Apr;26(4):622-8 PMID: 2330084
  3. Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox".
    Am J Physiol. 1992 Dec;263(6 Pt 2):H1901-6 PMID: 1282785
  4. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.
    Cell. 1993 Mar 26;72(6):835-46 PMID: 7681362
  5. Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.
    Acta Neuropathol. 1993;86(2):117-25 PMID: 8213067
  6. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.
    Cancer Res. 1993 Dec 1;53(23):5822-7 PMID: 7694795
  7. Determinants of human astrocytoma migration.
    Cancer Res. 1994 Jul 15;54(14):3897-904 PMID: 8033113
  8. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium.
    Eur J Cell Biol. 1994 Apr;63(2):247-54 PMID: 8082649
  9. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.
    Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):768-72 PMID: 7531342
  10. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Am J Pathol. 1996 Apr;148(4):1065-74 PMID: 8644848
  11. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.
    Cell. 1996 Aug 9;86(3):353-64 PMID: 8756718
  12. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.
    Nat Med. 1997 Feb;3(2):177-82 PMID: 9018236
  13. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
    Science. 1997 Jul 4;277(5322):55-60 PMID: 9204896
  14. Signaling vascular morphogenesis and maintenance.
    Science. 1997 Jul 4;277(5322):48-50 PMID: 9229772
  15. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells.
    Dev Growth Differ. 1997 Dec;39(6):729-40 PMID: 9493833
  16. Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse.
    J Cereb Blood Flow Metab. 1998 May;18(5):510-20 PMID: 9591843
  17. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis.
    Am J Pathol. 1998 Nov;153(5):1459-66 PMID: 9811337
  18. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
    Lab Invest. 1998 Nov;78(11):1385-94 PMID: 9840613
  19. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.
    J Clin Invest. 1999 Jan;103(2):159-65 PMID: 9916127
  20. In situ hybridization with RNA probes.
    Methods Mol Biol. 1999;96:107-17 PMID: 10098127
  21. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
    Science. 1999 Jun 18;284(5422):1994-8 PMID: 10373119
  22. Molecular and biological properties of vascular endothelial growth factor.
    J Mol Med (Berl). 1999 Jul;77(7):527-43 PMID: 10494799
  23. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.
    Oncogene. 1999 Sep 20;18(38):5356-62 PMID: 10498889
  24. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis.
    Exp Neurol. 1999 Oct;159(2):391-400 PMID: 10506510
  25. Glioma cell migration is associated with glioma-induced angiogenesis in vivo.
    Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):557-63 PMID: 10571417
  26. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models.
    J Natl Cancer Inst. 2000 Jan 19;92(2):143-7 PMID: 10639516
  27. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Cancer Res. 2000 Jan 15;60(2):203-12 PMID: 10667560
  28. Vascularization of human glioma spheroids implanted into rat cortex is conferred by two distinct mechanisms.
    J Neurosci Res. 1999 Feb 15;55(4):486-95 PMID: 10723058
  29. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.
    Neoplasia. 2000 Jan-Apr;2(1-2):53-61 PMID: 10933068
  30. Vascular-specific growth factors and blood vessel formation.
    Nature. 2000 Sep 14;407(6801):242-8 PMID: 11001067
  31. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.
    Oncogene. 2000 Sep 14;19(39):4549-52 PMID: 11002428
  32. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging.
    Neurosurgery. 2000 Oct;47(4):921-9; discussion 929-30 PMID: 11014432
  33. Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences.
    Cancer Res. 2000 Nov 1;60(21):6142-7 PMID: 11085538
  34. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Cancer Res. 2001 Mar 1;61(5):2145-53 PMID: 11280779
  35. Tie receptors: new modulators of angiogenic and lymphangiogenic responses.
    Nat Rev Mol Cell Biol. 2001 Apr;2(4):257-67 PMID: 11283723
  36. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair.
    Lab Invest. 2001 Mar;81(3):361-73 PMID: 11310829
  37. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
    Cancer Res. 2001 Aug 15;61(16):6248-54 PMID: 11507079
  38. Tumor angiogenesis: therapeutic implications.
    N Engl J Med. 1971 Nov 18;285(21):1182-6 PMID: 4938153
  39. Tumor dormancy in vivo by prevention of neovascularization.
    J Exp Med. 1972 Aug 1;136(2):261-76 PMID: 5043412
  40. The biology of malignant gliomas--a comprehensive survey.
    Clin Neuropathol. 1984 May-Jun;3(3):93-106 PMID: 6205806
  41. Cell and environment interactions in tumor microregions: the multicell spheroid model.
    Science. 1988 Apr 8;240(4849):177-84 PMID: 2451290
  42. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
    Nature. 1992 Oct 29;359(6398):845-8 PMID: 1279432
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2002-03-00
Pages
777-85
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC150910
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com